Home
>
National Drug Code (NDC)
>
Testopel
Testopel - 43773-1001-2 - (TESTOSTERONE)
Drug Information of Testopel
| Product NDC: | 43773-1001 |
| Proprietary Name: | Testopel |
| Non Proprietary Name: | TESTOSTERONE |
| Active Ingredient(s): | 75 mg/1 & nbsp; TESTOSTERONE |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | PELLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Testopel
| Product NDC: | 43773-1001 |
| Labeler Name: | Slate Pharma |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA080911 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20090721 |
Package Information of Testopel
| Package NDC: | 43773-1001-2 |
| Package Description: | 10 AMPULE in 1 BOX (43773-1001-2) > 1 PELLET in 1 AMPULE |
NDC Information of Testopel
| NDC Code | 43773-1001-2 |
| Proprietary Name | Testopel |
| Package Description | 10 AMPULE in 1 BOX (43773-1001-2) > 1 PELLET in 1 AMPULE |
| Product NDC | 43773-1001 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | TESTOSTERONE |
| Dosage Form Name | PELLET |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20090721 |
| Marketing Category Name | ANDA |
| Labeler Name | Slate Pharma |
| Substance Name | TESTOSTERONE |
| Strength Number | 75 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Androgen [EPC],Androgen Receptor Agonists [MoA],Androstanes [Chemical/Ingredient] |
